ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 53 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,189 | +51.1% | 56,190 | +75.1% | 0.00% | – |
| Q2 2023 | $154,372 | +18.2% | 32,094 | -0.2% | 0.00% | – |
| Q1 2023 | $130,562 | -29.7% | 32,158 | -6.5% | 0.00% | – |
| Q4 2022 | $185,674 | -28.3% | 34,384 | +33.6% | 0.00% | – |
| Q3 2022 | $259,000 | +156.4% | 25,742 | +19.5% | 0.00% | – |
| Q2 2022 | $101,000 | -88.0% | 21,546 | -90.0% | 0.00% | – |
| Q1 2022 | $845,000 | +31.6% | 216,168 | +127.6% | 0.00% | – |
| Q4 2021 | $642,000 | -50.6% | 94,984 | +8.7% | 0.00% | – |
| Q3 2021 | $1,299,000 | – | 87,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $14,180,861 | 4.20% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,758,317 | 3.16% |
| Altium Capital Management LP | 650,000 | $2,697,500 | 1.41% |
| RA Capital Management | 14,932,063 | $61,968,061 | 1.22% |
| GREAT POINT PARTNERS LLC | 1,074,101 | $4,457,519 | 0.81% |
| Boxer Capital, LLC | 2,206,983 | $9,158,979 | 0.49% |
| Deep Track Capital, LP | 2,513,044 | $10,429,133 | 0.40% |
| Parkman Healthcare Partners LLC | 499,814 | $2,074,228 | 0.38% |
| Rock Springs Capital Management LP | 2,812,579 | $11,672,203 | 0.31% |
| Ghost Tree Capital, LLC | 150,000 | $622,500 | 0.20% |